HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

Recruiting now · Not applicable

Conditions studied: Alzheimer Disease, Dementia, Hearing Loss, Cognitive Impairment

In brief

This randomized controlled trial study aims to evaluate a revised hearing care intervention for older adults with Alzheimer's Disease and Related Dementias (ADRD). The community-delivered hearing care intervention utilizes tailored strategies to assess impact on communication, neuropsychiatric symptoms (NPS), and care partner distress.

Key facts

Study ID

NCT06930560

Run by

Johns Hopkins University

People needed

300

Starts

2025-10-15

Expected to finish

2027-12-31

Last updated by the study team

2025-11-24

Who can join

Age: 60 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 60 - 100 years old
• English-speaking
• Diagnosis of probable Alzheimer's Disease or other related dementia according to the core clinical criteria outlined in the National Institute on Aging (NIA) and Alzheimer's Association Guidelines
• Speech frequency pure tone average (0.5- 4 kHz) >25 db in the better-hearing ear; adult onset hearing loss
• Availability of caregiver/study partner who is 18+ to participate in all study-related visits and who provides care supervision
• Stable (for 2 weeks or longer) dosing of medication (e.g. antidepressants, antipsychotics) for neuropsychiatric symptoms

You may not qualify if…

• Current self-reported use of hearing aid or amplification device
• Medical contraindication to use hearing aids ( e.g. draining ears)
• Inability to participate in the 1-month follow up

Where it is running

• Johns Hopkins Memory and Alzheimer's Treatment Center — Baltimore, Maryland, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.